tiprankstipranks
Trending News
More News >
Anebulo Pharmaceuticals (ANEB)
NASDAQ:ANEB
US Market

Anebulo Pharmaceuticals (ANEB) Income Statement

Compare
34 Followers

Anebulo Pharmaceuticals Income Statement

Last quarter (Q1 2026), Anebulo Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Anebulo Pharmaceuticals's net income was $-2.16M. See Anebulo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.22M$ 8.31M$ 11.78M$ 6.83M$ 3.61M
Depreciation and Amortization
$ 0.00$ 258.28K$ 0.00$ 0.00$ 0.00
EBITDA
$ -8.10M$ -7.79M$ -11.73M$ -6.83M$ -30.24M
Operating Income
$ -9.22M$ -8.31M$ -11.78M$ -6.83M$ -3.61M
Other Income/Expenses
$ 738.72K$ 107.05K$ 51.26K$ 5.55K$ -26.64M
Pretax Income
$ -8.48M$ -8.20M$ -11.73M$ -6.83M$ -30.25M
Net Income
$ -8.48M$ -8.20M$ -11.73M$ -6.83M$ -30.25M
Per Share Metrics
Basic EPS
$ -0.25$ -0.32$ -0.47$ -0.29$ -1.30
Diluted EPS
$ -0.25$ -0.32$ -0.47$ -0.29$ -1.30
Weighted Average Shares Outstanding
33.82M 25.82M 25.07M 23.34M 23.34M
Weighted Average Shares Outstanding (Diluted)
33.82M 25.82M 25.07M 23.34M 23.34M
Currency in USD

Anebulo Pharmaceuticals Earnings and Revenue History